Schedule 13G ownership disclosure

NEOLEUKIN THERAPEUTICS INC

Security class unavailable · CUSIP: 64049K104

Event date: 2022-12-20

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
2,291,133
Percent of class
5.3800%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000902664-22-005339
Form type
SC 13G
Filer
Lynx1 Capital Management LP
CIK
CIK 1910456
Filed
Dec 30, 2022
Reporting period
Dec 20, 2022
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub